Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Saved in:
| Title: | Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Jang JE; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul 06591, Republic of Korea., Kim HS; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul 06591, Republic of Korea., Kim JS; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul 06591, Republic of Korea., Han JM; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul 06591, Republic of Korea., Cho HS; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Tak KY; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Han JW; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Sung PS; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Bae SH; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Jang JW; The Catholic University Liver Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. |
| Source: | Biomedicines [Biomedicines] 2026 Feb 04; Vol. 14 (2). Date of Electronic Publication: 2026 Feb 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2227-9059 |
|---|---|
| DOI: | 10.3390/biomedicines14020364 |
